Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
The Lancet. Respiratory Medicine|April 3, 2019
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort studyMadeleine K D Scott, Katie Quinn, Qin Li, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
A Nerve-Fibroblast Axis in Mammalian Lung FibrosisGenta Ishikawa, Xueyan Peng, Alexander Ghincea, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung DiseaseShervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
The European Respiratory Journal|May 15, 2025
cGAS Expression is enhanced in systemic sclerosis associated interstitial lung disease and stimulates inflammatory myofibroblast activationSheeline Yu, Buqu Hu, Ying Sun, et al.
Nature Reviews. Rheumatology|February 14, 2025
An international perspective on the future of systemic sclerosis researchDavid J Abraham, Carol M Black, Christopher P Denton, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
cGAS Expression is Enhanced in Systemic Sclerosis Associated Interstitial Lung Disease and Stimulates Inflammatory Myofibroblast ActivationSheeline Yu, Buqu Hu, Ying Sun, et al.
Arthritis Care & Research|August 29, 2013
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registryLorinda Chung, Robyn T Domsic, Bharathi Lingala, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Machine Learning Analysis of Electronic Health Records Identifies Interstitial Lung Disease and Predicts Mortality in Patients with Systemic SclerosisAlec K Peltekian, Kevin M Grudzinski, Bradford C Bemiss, et al.
Clinical and Experimental Rheumatology|December 3, 2016
Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registryLorinda Chung, Robert M Fairchild, Daniel E Furst, et al.
Seminars in Arthritis and Rheumatism|January 13, 2015
Antinuclear antibody-negative systemic sclerosisGloria A Salazar, Shervin Assassi, Fredrick Wigley, et al.
Pageof 18